New York State Common Retirement Fund’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,252
| Closed | -$16K | – | 3440 |
|
|
2024
Q1 | $16K | Sell |
10,252
-20
| -0.2% | -$31 | ﹤0.01% | 3164 |
|
|
2023
Q4 | $9K | Hold |
10,272
| – | – | ﹤0.01% | 3198 |
|
|
2023
Q3 | $11K | Buy |
10,272
+126
| +1% | +$135 | ﹤0.01% | 3212 |
|
|
2023
Q2 | $26K | Hold |
10,146
| – | – | ﹤0.01% | 3219 |
|
|
2023
Q1 | $41K | Sell |
10,146
-16,300
| -62% | -$65.9K | ﹤0.01% | 3030 |
|
|
2022
Q4 | $133K | Sell |
26,446
-16
| -0.1% | -$80 | ﹤0.01% | 2879 |
|
|
2022
Q3 | $346K | Buy |
26,462
+3,752
| +17% | +$49.1K | ﹤0.01% | 2520 |
|
|
2022
Q2 | $291K | Sell |
22,710
-74
| -0.3% | -$948 | ﹤0.01% | 2618 |
|
|
2022
Q1 | $347K | Buy |
22,784
+20
| +0.1% | +$305 | ﹤0.01% | 2572 |
|
|
2021
Q4 | $403K | Sell |
22,764
-108
| -0.5% | -$1.91K | ﹤0.01% | 2547 |
|
|
2021
Q3 | $481K | Sell |
22,872
-4,335
| -16% | -$91.2K | ﹤0.01% | 2487 |
|
|
2021
Q2 | $537K | Buy |
27,207
+5,207
| +24% | +$103K | ﹤0.01% | 2566 |
|
|
2021
Q1 | $640K | Hold |
22,000
| – | – | ﹤0.01% | 2325 |
|
|
2020
Q4 | $666K | Hold |
22,000
| – | – | ﹤0.01% | 2212 |
|
|
2020
Q3 | $350K | Hold |
22,000
| – | – | ﹤0.01% | 2388 |
|
|
2020
Q2 | $434K | Hold |
22,000
| – | – | ﹤0.01% | 2291 |
|
|
2020
Q1 | $271K | Hold |
22,000
| – | – | ﹤0.01% | 2316 |
|
|
2019
Q4 | $407K | Buy |
22,000
+15,100
| +219% | +$279K | ﹤0.01% | 2402 |
|
|
2019
Q3 | $96K | Hold |
6,900
| – | – | ﹤0.01% | 3042 |
|
|
2019
Q2 | $101K | Buy |
+6,900
| New | +$101K | ﹤0.01% | 3106 |
|